Efficiency of Botulinum Toxin Type-a in the Management of the Myofascial Pain

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

December 12, 2024

Study Completion Date

February 13, 2025

Conditions

Myofascial Pain - Dysfunction Syndrome of TMJ

Interventions

DRUG

Botulinum Toxin A (Botox )

TX-A will be injected into the masseter and temporalis muscles (30 and 15 units per side, respectively) following a standardized protocol.

Trial Locations (1)

Hacettepe University, Ankara

All Listed Sponsors

lead

Hacettepe University

OTHER

NCT06840730 - Efficiency of Botulinum Toxin Type-a in the Management of the Myofascial Pain | Biotech Hunter | Biotech Hunter